Company intelligence / Profile preview
KPC Pharmaceuticals
Kunming, Yunnan, Chinaglobaldata.com ↗
- Ownership
- Private
- Employees
- ~5051
- Development stage
- Other
01
Overview
KPC Pharmaceuticals has a broad portfolio of commercialized botanical and natural medicine products. Its marketed drugs include artemisinin-based antimalarials and treatments for CNS and cardiovascular conditions. The company also has several pipeline programs in development focused on natural medicines[1][3][4]. Clinical results are consistent with established efficacy for botanical therapies in their approved indications.
- Therapeutic areas
- CardiovascularNeurologyInfectious DiseasesOther
- Modalities
- Small moleculeBotanical drugHerbal medicine
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on KPC Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KPC Pharmaceuticals.